269 related articles for article (PubMed ID: 15829534)
1. DNA topoisomerase II in therapy-related acute promyelocytic leukemia.
Mistry AR; Felix CA; Whitmarsh RJ; Mason A; Reiter A; Cassinat B; Parry A; Walz C; Wiemels JL; Segal MR; Adès L; Blair IA; Osheroff N; Peniket AJ; Lafage-Pochitaloff M; Cross NC; Chomienne C; Solomon E; Fenaux P; Grimwade D
N Engl J Med; 2005 Apr; 352(15):1529-38. PubMed ID: 15829534
[TBL] [Abstract][Full Text] [Related]
2. Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci.
Hasan SK; Ottone T; Schlenk RF; Xiao Y; Wiemels JL; Mitra ME; Bernasconi P; Di Raimondo F; Stanghellini MT; Marco P; Mays AN; Döhner H; Sanz MA; Amadori S; Grimwade D; Lo-Coco F
Genes Chromosomes Cancer; 2010 Aug; 49(8):726-32. PubMed ID: 20544846
[TBL] [Abstract][Full Text] [Related]
3. Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia.
Mays AN; Osheroff N; Xiao Y; Wiemels JL; Felix CA; Byl JA; Saravanamuttu K; Peniket A; Corser R; Chang C; Hoyle C; Parker AN; Hasan SK; Lo-Coco F; Solomon E; Grimwade D
Blood; 2010 Jan; 115(2):326-30. PubMed ID: 19884644
[TBL] [Abstract][Full Text] [Related]
4. Insights into leukemogenesis from therapy-related leukemia.
Pedersen-Bjergaard J
N Engl J Med; 2005 Apr; 352(15):1591-4. PubMed ID: 15829541
[No Abstract] [Full Text] [Related]
5. Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis.
Hasan SK; Mays AN; Ottone T; Ledda A; La Nasa G; Cattaneo C; Borlenghi E; Melillo L; Montefusco E; Cervera J; Stephen C; Satchi G; Lennard A; Libura M; Byl JA; Osheroff N; Amadori S; Felix CA; Voso MT; Sperr WR; Esteve J; Sanz MA; Grimwade D; Lo-Coco F
Blood; 2008 Oct; 112(8):3383-90. PubMed ID: 18650449
[TBL] [Abstract][Full Text] [Related]
6. [Molecular study of the mechanism of chromosomal translocation (15;17) in acute promyelocytic leukemia (APL)].
Dong S; Tong J; Wu Y; Cai J; Sun G; Chen S; Wang Z; Chen S; Chen Z; Geng J
Yi Chuan Xue Bao; 1993; 20(5):381-8. PubMed ID: 8161469
[TBL] [Abstract][Full Text] [Related]
7. Chromatin structural elements and chromosomal translocations in leukemia.
Zhang Y; Rowley JD
DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the t(15;17) translocation in de novo and secondary acute promyelocytic leukemia.
Naoe T; Kudo K; Yoshida H; Horibe K; Ohno R
Leukemia; 1997 Apr; 11 Suppl 3():287-8. PubMed ID: 9209367
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous DNA lesions poison human topoisomerase IIalpha and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints.
Kingma PS; Greider CA; Osheroff N
Biochemistry; 1997 May; 36(20):5934-9. PubMed ID: 9166762
[TBL] [Abstract][Full Text] [Related]
10. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Lovett BD; Lo Nigro L; Rappaport EF; Blair IA; Osheroff N; Zheng N; Megonigal MD; Williams WR; Nowell PC; Felix CA
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9802-7. PubMed ID: 11493704
[TBL] [Abstract][Full Text] [Related]
11. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
[TBL] [Abstract][Full Text] [Related]
12. [A preliminary study of the relation between topoisomerase I and translocation (15;17)].
Dong S; Tong J; Chen S
Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):88-92. PubMed ID: 9206036
[TBL] [Abstract][Full Text] [Related]
13. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].
Dassonneville L; Bailly C
Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316
[TBL] [Abstract][Full Text] [Related]
14. Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis.
Ramkumar B; Chadha MK; Barcos M; Sait SN; Heyman MR; Baer MR
Cancer Genet Cytogenet; 2008 Apr; 182(2):126-9. PubMed ID: 18406875
[TBL] [Abstract][Full Text] [Related]
15. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
Snijder S; Mellink CH; van der Lelie H
Cancer Genet Cytogenet; 2008 Jan; 180(2):149-52. PubMed ID: 18206542
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction.
Chen SJ; Chen Z; Chen A; Tong JH; Dong S; Wang ZY; Waxman S; Zelent A
Oncogene; 1992 Jun; 7(6):1223-32. PubMed ID: 1375719
[TBL] [Abstract][Full Text] [Related]
17. Predisposition to therapy-related acute leukemia with balanced chromosomal translocations does not result from a major constitutive defect in DNA double-strand break end joining.
Coiteux V; Onclercq-Delic R; Fenaux P; Amor-Guéret M
Leuk Res; 2007 Mar; 31(3):353-8. PubMed ID: 16890283
[TBL] [Abstract][Full Text] [Related]
18. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
19. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
[TBL] [Abstract][Full Text] [Related]
20. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
Cimoli G; Valenti M; Parodi S; Mazzoni A; De Sessa F; Conte P; Russo P
Oncol Res; 1993; 5(8):311-23. PubMed ID: 8012063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]